Literature DB >> 30675908

Proposal for a new classification for perihilar cholangiocarcinoma based on tumour depth.

K Shinohara1,2, T Ebata1, Y Shimoyama2, M Nakaguro2, T Mizuno1, K Matsuo3, M Nagino1.   

Abstract

BACKGROUND: The T system for distal cholangiocarcinoma has been revised from a layer-based to a depth-based approach in the current American Joint Committee on Cancer (AJCC) classification. In perihilar cholangiocarcinoma, tumour depth in the staging scheme has not yet been addressed. The aim of this study was to propose a new T system using measured tumour depth in perihilar cholangiocarcinoma.
METHODS: Patients who underwent hepatectomy for perihilar cholangiocarcinoma between 2001 and 2014 were reviewed retrospectively. The vertical distance between the top of the tumour and deepest invasive cells was measured as invasive tumour thickness (ITT) by two independent pathologists. Log rank statistics were used to determine cut-off points, and the concordance (C) index was used to assess survival discrimination of each T system.
RESULTS: ITT was measurable in all 440 patients, with a median value of 6·0 (range 0-45) mm. The median difference in ITT between observers was 0·6 (range 0-20) mm. Cut-off points for prognosis were 1, 5 and 8 mm. Five-year survival decreased with increasing ITT (P < 0·001): 67 per cent for ITT less than 1 mm (25 patients), 54·9 per cent for ITT 1 mm and over to less than 5 mm (138 patients), 43·4 per cent for ITT 5 mm and over to less than 8 mm (118 patients), and 32·2 per cent for ITT 8 mm and over (159 patients). The C-index of this classification was comparable to that of the current AJCC T classification (0·598 versus 0·589).
CONCLUSION: ITT is a reliable approach for making a depth assessment in perihilar cholangiocarcinoma. A four-tier ITT classification with cut-off points of 1, 5 and 8 mm is an adequate alternative to the current layer-based T classification.
© 2019 BJS Society Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2019        PMID: 30675908     DOI: 10.1002/bjs.11063

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System.

Authors:  Jong Woo Lee; Jae Hoon Lee; Yejong Park; Woohyung Lee; Jaewoo Kwon; Ki Byung Song; Dae Wook Hwang; Song Cheol Kim
Journal:  Cancer Res Treat       Date:  2020-03-12       Impact factor: 4.679

2.  A case of small in situ perihilar cholangiocarcinoma incidentally accompanied by benign bile duct stricture after open cholecystectomy.

Authors:  Takashi Maeda; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Takashi Mizuno; Junpei Yamaguchi; Shunsuke Onoe; Nobuyuki Watanabe; Masato Nagino
Journal:  Surg Case Rep       Date:  2019-11-09

3.  Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.

Authors:  Jian Zhao; Wei Zhang; Jun Zhang; Yi Zhang; Wen-Jie Ma; Si-Yun Liu; Fu-Yu Li; Bin Song
Journal:  BMC Cancer       Date:  2020-09-03       Impact factor: 4.430

4.  Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand.

Authors:  Chaiwat Aphivatanasiri; Prakasit Sa-Ngiamwibool; Sakkarn Sangkhamanon; Piyapharom Intarawichian; Waritta Kunprom; Malinee Thanee; Piya Prajumwongs; Narong Khuntikeo; Attapol Titapun; Apiwat Jareanrat; Vasin Thanasukarn; Tharatip Srisuk; Vor Luvira; Kulyada Eurboonyanun; Julaluck Promsorn; Watcharin Loilome; Aileen Wee; Supinda Koonmee
Journal:  Front Med (Lausanne)       Date:  2022-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.